Bank of New York Mellon Corp cut its holdings in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Free Report) by 7.9% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 110,226 shares of the company’s stock after selling 9,514 shares during the period. Bank of New York Mellon Corp’s holdings in Aveanna Healthcare were worth $504,000 at the end of the most recent quarter.
Other large investors have also added to or reduced their stakes in the company. Intech Investment Management LLC acquired a new stake in Aveanna Healthcare in the 3rd quarter valued at $69,000. XTX Topco Ltd bought a new position in shares of Aveanna Healthcare in the 3rd quarter valued at about $92,000. Legato Capital Management LLC acquired a new stake in shares of Aveanna Healthcare in the fourth quarter valued at about $83,000. Virtu Financial LLC bought a new stake in Aveanna Healthcare during the third quarter worth about $99,000. Finally, SG Americas Securities LLC boosted its position in Aveanna Healthcare by 26.0% during the fourth quarter. SG Americas Securities LLC now owns 24,366 shares of the company’s stock valued at $111,000 after purchasing an additional 5,031 shares during the last quarter. Institutional investors and hedge funds own 87.96% of the company’s stock.
Aveanna Healthcare Stock Up 2.6 %
NASDAQ:AVAH opened at $5.52 on Friday. The firm has a market capitalization of $1.08 billion, a price-to-earnings ratio of -16.23 and a beta of 2.25. Aveanna Healthcare Holdings Inc. has a 12-month low of $2.11 and a 12-month high of $6.19. The stock’s 50 day moving average price is $4.72 and its two-hundred day moving average price is $4.96.
Insider Buying and Selling at Aveanna Healthcare
Wall Street Analyst Weigh In
Several research analysts have weighed in on the company. Truist Financial lowered their price target on Aveanna Healthcare from $6.00 to $5.25 and set a “hold” rating on the stock in a research report on Monday, January 6th. UBS Group boosted their target price on shares of Aveanna Healthcare from $3.20 to $4.50 and gave the stock a “sell” rating in a report on Friday, March 14th.
Check Out Our Latest Stock Report on Aveanna Healthcare
Aveanna Healthcare Profile
Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.
Recommended Stories
- Five stocks we like better than Aveanna Healthcare
- Short Selling: How to Short a Stock
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to Sell
- The 3 Best Fintech Stocks to Buy Now
- Top 3 Beverage Stocks Pouring Out Profits
- How to Calculate Retirement Income: MarketBeat’s Calculator
- CarMax and Carvana: Steering the Used Car Market
Want to see what other hedge funds are holding AVAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Free Report).
Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.